Safety of Sports for Athletes With Implantable Cardioverter-Defibrillators: Results of a Prospective, Multinational Registry
暂无分享,去创建一个
M. Link | H. Heidbuchel | H. Calkins | D. Cannom | B. Maron | B. Wilkoff | M. Ackerman | C. Berul | D. Zipes | M. Scheinman | J. Dziura | N. Estes | E. Saarel | R. Lampert | F. Marcus | B. Olshansky | C. Brandt | A. Cheng | I. Law | C. Lawless | Fangyong Li | Michele Loomis | C. Barth | Cheryl Barth | M. Ackerman
[1] Wojciech Zareba,et al. Reduction in inappropriate therapy and mortality through ICD programming. , 2012, The New England journal of medicine.
[2] Hein Heidbuchel,et al. Ventricular arrhythmias associated with long-term endurance sports: what is the evidence? , 2012, British Journal of Sports Medicine.
[3] M. Barry,et al. Shared decision making--pinnacle of patient-centered care. , 2012, The New England journal of medicine.
[4] A. Zwinderman,et al. Therapeutic approach for patients with catecholaminergic polymorphic ventricular tachycardia: state of the art and future developments. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[5] R. Duncan,et al. Adolescents with Implantable Cardioverter Defibrillators: A Patient and Parent Perspective , 2012, Pacing and clinical electrophysiology : PACE.
[6] A. Skanes,et al. Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia. , 2011, Heart rhythm.
[7] W. Maisel,et al. 34 – Guidelines for Managing Pacemaker and Implantable Defibrillator Advisories , 2011 .
[8] P. Heidenreich,et al. Long-Term Outcome After ICD and CRT Implantation and Influence of Remote Device Follow-Up: The ALTITUDE Survival Study , 2010, Circulation.
[9] Vicki L Zeigler,et al. Determining Psychosocial Research Priorities for Adolescents With Implantable Cardioverter Defibrillators Using Delphi Methodology , 2010, The Journal of cardiovascular nursing.
[10] L. Salberg,et al. Patient Advocacy: What Is Its Role? , 2009, Pacing and clinical electrophysiology : PACE.
[11] Stephen L Moore,et al. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. , 2008, Journal of the American College of Cardiology.
[12] J. Triedman,et al. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. , 2008, Journal of the American College of Cardiology.
[13] A. Moss,et al. Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy. , 2007, Heart rhythm.
[14] V. Shusterman,et al. Implantable Cardioverter‐Defibrillator Shocks Increase T‐Wave Alternans , 2007, Journal of cardiovascular electrophysiology.
[15] Angelo Auricchio,et al. Clinical Cardiac Pacing, Defibrillation and Resynchronization Therapy , 2007 .
[16] G. Breithardt,et al. Age- and Training-Dependent Development of Arrhythmogenic Right Ventricular Cardiomyopathy in Heterozygous Plakoglobin-Deficient Mice , 2006, Circulation.
[17] Pietro Delise,et al. Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions Part II: Ventricular arrhythmias, channelopathies and implantable defibrillators , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[18] D. Cannom,et al. Safety of Sports Participation in Patients with Implantable Cardioverter Defibrillators: A Survey of Heart Rhythm Society Members , 2006, Journal of cardiovascular electrophysiology.
[19] Douglas L Packer,et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.
[20] R. Bonow,et al. 36th Bethesda Conference: Eligibility Recommendations for Competitive Athletes With Cardiovascular Abnormalities , 2005 .
[21] M. Link,et al. Implantable Cardioverter-Defibrillator Therapy for Prevention of Sudden Death in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia , 2003, Circulation.
[22] Maurizio Schiavon,et al. Does sports activity enhance the risk of sudden death in adolescents and young adults? , 2003, Journal of the American College of Cardiology.
[23] L. Fananapazir,et al. Efficacy of Implantable Cardioverter Defibrillator Therapy for Primary and Secondary Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy , 2003, Pacing and clinical electrophysiology : PACE.
[24] H. Heidbuchel,et al. High prevalence of right ventricular involvement in endurance athletes with ventricular arrhythmias. Role of an electrophysiologic study in risk stratification. , 2003, European heart journal.
[25] A. Moss,et al. Implantable Cardioverter Defibrillator in High‐Risk Long QT Syndrome Patients , 2003, Journal of cardiovascular electrophysiology.
[26] Diwakar Jain,et al. Emotional and Physical Precipitants of Ventricular Arrhythmia , 2002, Circulation.
[27] J. Kluger,et al. Ineffective ICD Therapy Due to Excessive Alcohol and Exercise , 2002, Pacing and clinical electrophysiology : PACE.
[28] R. Ideker,et al. Impact of Myocardial Ischemia and Reperfusion on Ventricular Defibrillation Patterns, Energy Requirements, and Detection of Recovery , 2002, Circulation.
[29] J. Oss,et al. PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .
[30] Judy Powell,et al. Quality of Life in the Antiarrhythmics Versus Implantable Defibrillators Trial: Impact of Therapy and Influence of Adverse Symptoms and Defibrillator Shocks , 2002, Circulation.
[31] A. Motamedi,et al. Quality of Life Assessment in Elite Collegiate Athletes * , 2001, The American journal of sports medicine.
[32] M. Link,et al. Report of the NASPE Policy Conference on Arrhythmias and the Athlete , 2001, Journal of cardiovascular electrophysiology.
[33] Y. Deychak,et al. Electrophysiologic basis by which epinephrine facilitates defibrillation after prolonged episodes of ventricular fibrillation. , 2001, Annals of emergency medicine.
[34] D. Wyse,et al. Electrical Storm Presages Nonsudden Death: The Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial , 2001, Circulation.
[35] B. Maron,et al. The paradox of exercise. , 2000, The New England journal of medicine.
[36] J. Manson,et al. Triggering of sudden death from cardiac causes by vigorous exertion. , 2000, The New England journal of medicine.
[37] M. Link,et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.
[38] K. Lee,et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. , 1999, The New England journal of medicine.
[39] C. Schuger,et al. Sudden death in implantable cardioverter-defibrillator recipients: clinical context, arrhythmic events and device responses. , 1999, Journal of the American College of Cardiology.
[40] F O Mueller,et al. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. , 1996, JAMA.
[41] H. Calkins,et al. Effect of epinephrine on the efficacy of the internal cardioverter-defibrillator. , 1992, The American journal of cardiology.
[42] O. Sejersted,et al. Plasma potassium changes with high intensity exercise. , 1990, The Journal of physiology.